Keytruda and Padcev improve event-free and overall survival for adults with muscle invasive bladder cancer who cannot receive ...

New technology is evolving lung cancer detection and treatment at Ascension Sacred Heart Bay in Panama City. It’s called the ...

The lidERA Breast Cancer study is a phase 3, randomized, open-label trial testing whether the adjuvant therapy giredestrant ...

The U.S. Food and Drug Administration (FDA) on Friday approved injectable and intravenous versions of Merck’s (MRK) ...

A collaborative research team, led by scientists at VCU Massey Comprehensive Cancer Center and Huntsman Cancer Institute at ...

Roswell Park Comprehensive Cancer Center has unveiled the new EDDY Mobile Breast & Prostate Cancer Screening Center, ...

We have new technology it’s a robotic it’s called ion and what it allows us to do is use a cat scan or a picture of the ...

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced that the U.S. Food and Drug ...

The Food and Drug Administration approved Merck's Keytruda in combination with Padcev to treat certain adults with muscle invasive bladder cancer (MIBC).

Radiation therapy plays a vital role in breast cancer treatment. Get clear information on how it works, its benefits, and how ...

Exact Sciences markets Cologuard as a non-invasive, convenient test. The traditional method of testing for colorectal cancer ...

The FDA approved pembrolizumab or pembrolizumab and berahyaluronidase alfa-pmph in combination with enfortumab vedotin-ejfv ...